1. Home
  2. DCTH vs NATH Comparison

DCTH vs NATH Comparison

Compare DCTH & NATH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Delcath Systems Inc.

DCTH

Delcath Systems Inc.

HOLD

Current Price

$11.11

Market Cap

363.5M

Sector

Health Care

ML Signal

HOLD

Logo Nathan's Famous Inc.

NATH

Nathan's Famous Inc.

HOLD

Current Price

$100.78

Market Cap

412.2M

ML Signal

HOLD

Company Overview

Basic Information
Metric
DCTH
NATH
Founded
1988
1916
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
363.5M
412.2M
IPO Year
2015
1996

Fundamental Metrics

Financial Performance
Metric
DCTH
NATH
Price
$11.11
$100.78
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$22.00
N/A
AVG Volume (30 Days)
378.1K
17.3K
Earning Date
05-07-2026
06-09-2026
Dividend Yield
N/A
1.99%
EPS Growth
107.53
22.29
EPS
N/A
4.17
Revenue
N/A
$104,201,000.00
Revenue This Year
$24.54
N/A
Revenue Next Year
$33.15
N/A
P/E Ratio
N/A
$24.21
Revenue Growth
N/A
7.81
52 Week Low
$8.12
$88.67
52 Week High
$18.23
$118.32

Technical Indicators

Market Signals
Indicator
DCTH
NATH
Relative Strength Index (RSI) 53.27 50.98
Support Level $10.17 $100.01
Resistance Level $11.24 $101.89
Average True Range (ATR) 0.56 0.55
MACD -0.02 0.01
Stochastic Oscillator 46.85 64.72

Price Performance

Historical Comparison
DCTH
NATH

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. The company is focused on the treatment of primary and metastatic liver cancers. The firm's product include Melphalan Hydrochloride, Hepzato for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

About NATH Nathan's Famous Inc.

Nathan's Famous Inc is an owner of fast food franchises in the United States. The company's reportable segment includes the Branded Product Program, Product licensing, Restaurant operations and Corporate. Branded Product Program derives revenue principally from the sale of hot dog products either directly to foodservice operators or to various foodservice distributors who resell the products to foodservice operators. It generates maximum revenue from the Branded Product Program segment. Geographically, it derives a majority of revenue from the United States.

Share on Social Networks: